Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz von Nussbaum

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Angewandte Chemie (International Ed. in English)|March 19, 2009
Lost in transcription--inhibition of RNA polymeraseDieter Haebich, Franz von Nussbaum
Angewandte Chemie (International Ed. in English)|September 27, 2014
Aspergillomarasmine A, an inhibitor of bacterial metallo-β-lactamases conferring blaNDM and blaVIM resistanceFranz von Nussbaum, Guido Schiffer
Journal of Medicinal Chemistry|February 17, 2025
Opening the Door to a New Treatment Paradigm: The Re-emergence of Chymase InhibitorsFranz von Nussbaum, Giambattista Testolin
Bioorganic & Medicinal Chemistry Letters|September 12, 2015
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophoresFranz von Nussbaum, Volkhart M-J Li
Angewandte Chemie (International Ed. in English)|August 2, 2006
Antibacterial natural products in medicinal chemistry--exodus or revival?Franz von Nussbaum, Michael Brands, Berthold Hinzen, et al.
Chemmedchem|March 23, 2026
Strategic Key Performance Indicators for AI in Lead OptimizationTheodor Theis, Stefanie Flohr, Hayley Binch, et al.
Chemmedchem|February 5, 2008
Total synthesis and initial structure-activity relationships of longicatenamycin AFranz von Nussbaum, Sonja Anlauf, Christoph Freiberg, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
An Iron(III)-Catechol Complex as a Mushroom PigmentFranz von Nussbaum, Peter Spiteller, Matthias Rüth, et al.
Chemmedchem|October 5, 2022
Frontiers in Medicinal Chemistry 2022 Goes VirtualEleonora Diamanti, María Méndez, Tatjana Ross, et al.
Elife|February 18, 2016
Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524Anna P Baron, Conrad von Schubert, Fabien Cubizolles, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|March 19, 2009
Lost in transcription--inhibition of RNA polymeraseDieter Haebich, Franz von Nussbaum
Angewandte Chemie (International Ed. in English)|September 27, 2014
Aspergillomarasmine A, an inhibitor of bacterial metallo-β-lactamases conferring blaNDM and blaVIM resistanceFranz von Nussbaum, Guido Schiffer
Journal of Medicinal Chemistry|February 17, 2025
Opening the Door to a New Treatment Paradigm: The Re-emergence of Chymase InhibitorsFranz von Nussbaum, Giambattista Testolin
Bioorganic & Medicinal Chemistry Letters|September 12, 2015
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophoresFranz von Nussbaum, Volkhart M-J Li
Angewandte Chemie (International Ed. in English)|August 2, 2006
Antibacterial natural products in medicinal chemistry--exodus or revival?Franz von Nussbaum, Michael Brands, Berthold Hinzen, et al.
Chemmedchem|March 23, 2026
Strategic Key Performance Indicators for AI in Lead OptimizationTheodor Theis, Stefanie Flohr, Hayley Binch, et al.
Chemmedchem|February 5, 2008
Total synthesis and initial structure-activity relationships of longicatenamycin AFranz von Nussbaum, Sonja Anlauf, Christoph Freiberg, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
An Iron(III)-Catechol Complex as a Mushroom PigmentFranz von Nussbaum, Peter Spiteller, Matthias Rüth, et al.
Chemmedchem|October 5, 2022
Frontiers in Medicinal Chemistry 2022 Goes VirtualEleonora Diamanti, María Méndez, Tatjana Ross, et al.
Elife|February 18, 2016
Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524Anna P Baron, Conrad von Schubert, Fabien Cubizolles, et al.
Pageof 3